adamfeuerstein
I am a senior columnist at TheStreet, covering the biotechnology and drug sectors.

keryxbiopharma
Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease.

herbgreenberg
Senior Stocks Commentator for CNBC.

BrianSozzi

JimCramer
I am co-founder and chairman of TheStreet. I run the charitable trust portfolio, Action Alerts PLUS, and host CNBC's Mad Money television program.